He's Just Being Frank - Pharmaceutical Executive

ADVERTISEMENT

He's Just Being Frank
Cephalon's boss brought Provigil to market, runs his biotech like a Big Pharma, and mouths off at you-know-who. Now he's going global with plans to corner cancer. The really scary thing is, Baldino, 53, hasn't even peaked.


Pharmaceutical Executive


The practiced modesty may be new—and not his native style—but the substance is old-school Baldino. Although predictions in pharma are folly, with Cephalon stock and strategy stronger than ever, no one should be surprised to see its boss still playing at the big table—placing bets and winning—in another 20 years.

This online version incorporates corrections made in the printed version.


ADVERTISEMENT

blog comments powered by Disqus
UPCOMING CONFERENCES

Serialization Summit
San Diego, CA
Feb. 27-28, 2014



Advances in Aseptic Processing
San Diego, CA
Mar. 10-12, 2014



ClinTech 2014
Cambridge, MA
Mar. 11-13 2014


Investigator-Initiated and
Sponsored Research (IISR)

Philadelphia, PA
Mar. 19-20 2014

See All Conferences >>

Source: Pharmaceutical Executive,
Click here